Treatments for hairloss, such as Minoxidil, finasteride, RU58841 and Eucapil; the legitimacy of RU58841 products; and safety concerns related to using RU58841.
The conversation discusses severe hairloss, possibly due to telogen effluvium or male pattern baldness, lasting over three years. Suggested treatments include minoxidil, finasteride, and dermarolling, with a recommendation to consult a dermatologist.
Finasteride is a controversial hairloss treatment, with some users experiencing positive results and others facing side effects like erectile dysfunction. The discussion emphasizes the importance of personal choice and informed decision-making.
The conversation discusses hairloss treatments, specifically the transition from topical to oral minoxidil and finasteride, and the associated shedding phase. Users advise patience and consistency, noting that shedding is common and improvement may take several months.
Justin Bieber's hairloss and his choice not to use finasteride or other treatments like rectal injection are discussed, with reasons speculated to be side effects or lack of concern. The conversation also mentions his past hair transplant and suggests his wealth and fame might make appearance less of a priority.
PP405 is a potential hairloss treatment that may activate dormant hair follicles, but there are concerns about its effectiveness, cost, and side effects. Users discuss treatments like minoxidil, finasteride, and RU58841, expressing skepticism about PP405's long-term success and accessibility.
The conversation discusses hairloss treatments, focusing on finasteride, minoxidil, and other options like PRP and ketoconazole. It highlights the importance of asking specific questions during a dermatology visit to determine the cause of hairloss and appropriate treatments.
The conversation discusses hairloss treatments, emphasizing the importance of patience and sticking with a treatment for at least 12-18 months before judging its effectiveness or adding new treatments. Users share experiences and agree that introducing treatments too quickly can lead to panic and negative outcomes.
A person is treating their hairloss with oral minoxidil (2.5mg), derma stamping, and dutasteride (0.5mg) for nearly a year but still feels their hair isn't dense enough to grow out. Commenters are generally supportive, noting progress and suggesting it may look denser than the person perceives.
The conversation lists hairloss treatments including finasteride, dutasteride, RU58841, pyrilutamide, breezula, and fluridil, and suggests ketoconazole as another option. Some users warn against using certain treatments like cyproterone acetate, bicalutamide, and spironolactone due to their strong anti-androgen effects and potential impact on masculinity.
Dutasteride doses matter for hairloss treatment and are more effective than finasteride. RU58841 is suggested for better gains, but side effect profiles should be considered.
Treatments for hairloss, including the effectiveness and safety of Pyrilutamide compared to RU58841; experiences using both medications with varying results; and recommendations to try Pyrilutamide instead of RU58841.
RU58841 was the only treatment that slowed hairloss and reduced irritation for a DUPA sufferer after trying finasteride, minoxidil, and dutasteride with no success. The user continues using 6mg oral minoxidil, 0.5mg dutasteride, and an 8% RU58841 solution.
A user embraced their hairloss by choosing a buzzed hairstyle and received positive feedback on their appearance. Some suggested acceptance and self-care, while others discussed the potential of hair regrowth with treatments like finasteride and minoxidil.
A 29-year-old male experienced hairloss and reduced libido after heavy drinking from 2020 to 2024, and began using finasteride (1mg daily) and minoxidil (5% topical, once daily) in January 2026, noticing thicker hair but no new regrowth after three months. He also introduced derma rolling in February and plans to continue treatment for 6–12 months before fully assessing results.
An 18-year-old is experiencing significant hairloss and is concerned about treatment options, including finasteride, minoxidil, and dutasteride, due to potential side effects and costs. They are also taking vitamins for deficiencies and considering alternatives like hair transplants or embracing the bald look.
Stopping Minoxidil caused significant hairloss, which was mostly regained after resuming 1mg Finasteride and 3mg oral Minoxidil. Consistent use of both treatments is essential for maintaining hair growth.
The user is experiencing ongoing hairloss despite using treatments like topical and oral finasteride, dutasteride, oral minoxidil, and RU58841. They are advised to consider a scalp biopsy and blood tests to determine the underlying cause, as their hairloss may not be related to DHT.
Finasteride is used for hairloss, with mixed reports of no side effects and claims of long-term negative effects known as Post Finasteride Syndrome (PFS). The conversation debates the existence and causes of PFS, with differing opinions on whether it is psychological or real.
People discuss hairloss treatments like minoxidil, finasteride, and dutasteride, sharing experiences and side effects. Opinions vary on combining treatments, with some skeptical and others reporting success.
Finasteride and Dutasteride are used to block DHT and treat hairloss, but some people don't respond to these treatments. Alternatives include increasing Dutasteride dosage, adding topical finasteride, or exploring other treatments like RU58841, though results vary.
The conversation is about hairloss treatments, specifically the lack of improvement after one year of using oral finasteride and topical minoxidil. Suggestions include switching to stronger medications like dutasteride and oral minoxidil, considering a hair transplant, and possibly using microneedling or tretinoin.
Young men experiencing hairloss are frustrated with advice to embrace baldness without exploring treatments. They advocate for using finasteride and minoxidil, considering hair transplants, and hope for future advancements in hair restoration.
PP405 is considered a potential new treatment for hairloss, compared to finasteride and minoxidil. There is skepticism about its effectiveness in humans, with anticipation for more information from an upcoming conference.
A user is experiencing hairloss despite using topical minoxidil, oral finasteride, and 2% ketoconazole shampoo, and is seeking advice on further treatments. Suggestions include switching to dutasteride, trying oral minoxidil, addressing scalp inflammation, and considering dietary changes and supplements.
A new hairloss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.